Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00342004 | A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women | completed | — | 75,366 | National Cancer Institute (NCI)NIH | 1 | Aug 4, 2020 | clinicaltrials |
| NCT02964416 | Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery | completed | Phase 4 | 80 | Aga Khan UniversityOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT00823459 | Everolimus in Treating Patients With Recurrent Low-Grade Glioma | completed | Phase 2 | 58 | Susan ChangOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT00342953 | Study of Health Effects of Cosmetic Breast Augmentation | completed | — | 17,424 | National Cancer Institute (NCI)NIH | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04454268 | Intracranial Hydatid Cyst | completed | N/A | 8 | Sohag UniversityOTHER | 0 | Jul 2, 2020 | clinicaltrials |
| NCT04425954 | Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery | completed | — | 14 | Federico II UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02502708 | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors | completed | Phase 1 | 81 | NewLink Genetics CorporationINDUSTRY | 1 | Jun 4, 2020 | clinicaltrials |
| NCT03123302 | Our Anesthesia Experience During MRI Scan | completed | — | 977 | Akdeniz UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01331135 | Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors(Aflac ST0901) | completed | Phase 1 | 18 | Emory UniversityOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT02220491 | Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases(Amadeus) | completed | N/A | 20 | British Columbia Cancer AgencyOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT00724191 | Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR) | completed | — | 88 | University of MichiganOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT02599142 | Comparing Immobilisation Shells in Cranial Radiotherapy(CORIOLIS) | completed | N/A | 41 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT02911155 | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | completed | — | 229 | National Cancer Institute (NCI)NIH | 1 | May 5, 2020 | clinicaltrials |
| NCT02431572 | A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03010943 | Brain Awake Surgery Using Virtual Reality Headset(CERVO1) | completed | N/A | 45 | University Hospital, AngersOTHER_GOV | 1 | Apr 27, 2020 | clinicaltrials |
| NCT02743481 | Early Life Exposures in Agriculture | completed | — | 60,000 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2020 | clinicaltrials |
| NCT01614132 | Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults(NOA-07) | completed | Phase 1 / Phase 2 | 33 | University of RegensburgOTHER | 1 | Mar 31, 2020 | clinicaltrials |
| NCT04313374 | Integrated Pulmonary Index and Opioid Based Patient Controlled Analgesia | completed | Phase 4 | 90 | Istanbul UniversityOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT01067469 | Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) | completed | Phase 2 | 83 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT00525590 | Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer | completed | Phase 2 | 69 | Eisai Inc.INDUSTRY | 1 | Mar 16, 2020 | clinicaltrials |
| NCT00062478 | Study of Karenitecin (BNP1350) in Patients With Brain Tumors | completed | Phase 2 | 40 | BioNumerik Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT00042367 | Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors(BB'98) | completed | N/A | 119 | Baylor College of MedicineOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03641443 | non_invasive_aICP_Tumor(aICPTumor) | completed | N/A | 48 | Kantonsspital AarauOTHER | 1 | Feb 26, 2020 | clinicaltrials |
| NCT01967810 | ANG1005 in Patients With Recurrent High-Grade Glioma | completed | Phase 2 | 73 | Angiochem IncINDUSTRY | 1 | Feb 25, 2020 | clinicaltrials |
| NCT00763750 | PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors | completed | Phase 2 | 25 | howard safranOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01498328 | A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma(ReACT) | completed | Phase 2 | 127 | Celldex TherapeuticsINDUSTRY | 1 | Feb 17, 2020 | clinicaltrials |
| NCT03871686 | Promotion of Well-being of Young Adult Brain Cancer Survivors | completed | N/A | 139 | University of Wisconsin, MadisonOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03525080 | Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors(GLIROPA) | completed | N/A | 16 | Center Eugene MarquisOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT02451215 | Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors | completed | N/A | 10 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT00939523 | Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy | completed | Phase 2 | 9 | Cedars-Sinai Medical CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT01222780 | To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer | completed | Phase 1 | 22 | Acrotech Biopharma Inc.INDUSTRY | 1 | Jan 18, 2020 | clinicaltrials |
| NCT02167204 | 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors | completed | N/A | 9 | University of WashingtonOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT02541370 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | completed | Phase 1 / Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00993057 | Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia | completed | Early Phase 1 | 120 | Northwestern UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01316809 | AZD8055 for Adults With Recurrent Gliomas | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00994071 | A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors | completed | Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | Dec 9, 2019 | clinicaltrials |
| NCT01540513 | PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404 | completed | N/A | 12 | University of Wisconsin, MadisonOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT04178330 | Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases | completed | N/A | 82 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT02357498 | Transsphenoidal Extent of Resection Study(TRANSSPHER) | completed | N/A | 260 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT02727686 | Post-Operative Water Load Following Transsphenoidal Pituitary Surgery | completed | N/A | 30 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT01392209 | Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT01516905 | PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 | completed | — | 19 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01654497 | Dexanabinol in Patients With Brain Cancer | completed | Phase 1 | 26 | Santosh Kesari, M.D., Ph.D.OTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT01272622 | Prospective Study of Children and Adolescents With Craniopharyngioma | completed | N/A | 120 | Klinikum Oldenburg gGmbHOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT00049127 | Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor | completed | Phase 1 / Phase 2 | 64 | Alliance for Clinical Trials in OncologyOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02537106 | A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation | completed | N/A | 100 | University Hospital Hradec KraloveOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT03710278 | The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)(LPat) | completed | — | 5 | Spartanburg Regional Healthcare SystemOTHER | 1 | Sep 18, 2019 | clinicaltrials |
| NCT02045368 | Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R | completed | Phase 1 | 92 | IGF Oncology, LLCINDUSTRY | 1 | Aug 22, 2019 | clinicaltrials |
| NCT01454596 | CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Aug 4, 2020source: clinicaltrials